European Respiratory Journal · 2001 · 56 citations · 6 references
MedicineOncologyPathologyChemotherapyMedical OncologyPulmonologyLung CancerMalignant NeoplasmsPulmonary PathologyPulmonary Toxicity ManagementRespiratory Pathology5-Fluorouracil Therapy5-Fluorouracil TreatmentAcute Lung InflammationAcute Lung Injury PathophysiologyCancer Therapy-related Pulmonary ToxicityChemotherapy-induced Pulmonary ToxicityOxaliplatin-based TherapyTransbronchial Biopsy
Diarrhoea, T-CD4+ lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and 5-fluorouracil for unresectable rectum carcinoma. The findings from transbronchial lung biopsy and bronchoalveolar lavage (BAL) were consistent with an organizing diffuse alveolar damage pattern. Once extensive microbiological studies proved negative, corticosteroids were given and a complete remission of clinical and radiological abnormalities was achieved. It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a pulmonary adverse reaction, a feature never previously associated with oxaliplatinum and 5-fluorouracil regimens.
6
Breast-conserving surgery in the neoadjuvant setting.
PubMed · 1998 · 259 citations
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)
I. Monnet, S. Brienza, F. Hugret et al. · European Journal of Cancer · 1998 · 72 citations
Medicine, Oncology, Pharmacology +13
Pathology of drug-induced lung disease
Jl Myers · Medical Entomology and Zoology · 1997 · 49 citations
High-resolution computed tomographic appearance of MALToma of the lung
G. L. McCulloch, R. Sinnatamby, Susan Stewart et al. · European Radiology · 1998 · 38 citations